Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
1.690
-0.085 (-4.79%)
At close: Nov 6, 2026, 4:00 PM EST
1.747
+0.057 (3.39%)
Pre-market: Nov 9, 2026, 4:11 AM EST

Evotec SE Revenue

Evotec SE had revenue of 164.93M EUR in the quarter ending September 30, 2026, with 0.63% growth. This brings the company's total for the last twelve months to 718.32M, down -5.03% year-over-year. In the year 2025, Evotec SE had annual revenue of 788.37M, down -1.08%.

Revenue (ttm)
718.32M EUR
Revenue Growth
-5.03%
P/S Ratio
0.77
Revenue / Employee
161,023 EUR
Employees
4,461
Market Cap
627.05M USD

Revenue Chart

* This company reports financials in EUR.

Revenue by Segment

By Segment

Chart
  • Discovery and Preclinical Development 529.28M 67.1%
  • Just - Evotec Biologics 259.59M 32.9%

By Geography

Chart
  • USA 431.51M 54.7%
  • Switzerland 161.61M 20.5%
  • Rest of the World 77.09M 9.8%
  • United Kingdom 61.72M 7.8%
  • Germany 25.29M 3.2%
  • France 19.86M 2.5%
  • Unallocated 11.29M 1.4%
Fiscal year ended Dec 31, 2025 See the full Evotec SE breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025788.37M-8.59M-1.08%
Dec 31, 2024796.97M15.54M1.99%
Dec 31, 2023781.43M29.98M3.99%
Dec 31, 2022751.45M133.41M21.59%
Dec 31, 2021618.03M117.11M23.38%
Dec 31, 2020500.92M54.49M12.20%
Dec 31, 2019446.44M71.03M18.92%
Dec 31, 2018375.41M111.64M42.33%
Dec 31, 2017263.77M99.26M60.34%
Dec 31, 2016164.51M36.83M28.85%
Dec 31, 2015127.68M38.18M42.66%
Dec 31, 201489.50M3.56M4.14%
Dec 31, 201385.94M-1.33M-1.52%
Dec 31, 201287.27M7.14M8.91%
Dec 31, 201180.13M24.87M45.00%
Dec 31, 201055.26M12.58M29.47%
Dec 31, 200942.68M3.07M7.75%
Dec 31, 200839.61M-14.77M-27.16%
Dec 31, 200754.38M-30.30M-35.78%
Dec 31, 200684.68M4.90M6.14%
Dec 31, 200579.79M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.